Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac N.V (CVAC) Net Income towards Common Stockholders: 2019-2025

Historic Net Income towards Common Stockholders for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to -$68.3 million.

  • CureVac N.V's Net Income towards Common Stockholders rose 9.27% to -$68.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $211.7 million, marking a year-over-year increase of 171.34%. This contributed to the annual value of $173.3 million for FY2024, which is 161.91% up from last year.
  • As of Q2 2025, CureVac N.V's Net Income towards Common Stockholders stood at -$68.3 million, which was down 26.83% from -$53.9 million recorded in Q1 2025.
  • CureVac N.V's Net Income towards Common Stockholders' 5-year high stood at $318.6 billion during Q2 2021, with a 5-year trough of -$467.1 billion in Q4 2021.
  • Moreover, its 3-year median value for Net Income towards Common Stockholders was -$70.8 million (2023), whereas its average is -$22.0 million.
  • The largest annual percentage gain for CureVac N.V's Net Income towards Common Stockholders in the last 5 years was 135,019,749.14% (2021), contrasted with its biggest fall of 713,346.98% (2021).
  • CureVac N.V's Net Income towards Common Stockholders (Quarterly) stood at -$467.1 billion in 2021, then surged by 99.97% to -$131.1 million in 2022, then rose by 28.81% to -$93.3 million in 2023, then decreased by 16.53% to -$108.7 million in 2024, then climbed by 9.27% to -$68.3 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$68.3 million for Q2 2025, versus -$53.9 million for Q1 2025 and -$108.7 million for Q4 2024.